The global anti-infective drug market is expected to grow at a rate of 26%

Global Anti-Infective Drugs Market Report 2022: Market Size, Trends and Forecast to 2026

Global Anti-Infective Drugs Market Report by Commercial Research Company 2022: Market Size, Trends and Forecast to 2026

LONDON, GREATER LONDON, United Kingdom, Aug. 31, 2022 / — According to The Business Research Company’s “Global Anti-Infective Drugs Market Report 2022”, the anti-infective drugs market size is expected to to grow from $220.00 billion in 2021 to $246.80 billion in 2022 at a compound annual growth rate (CAGR) of 12.2% The change in growth trend of Anti-Infective Drugs market is mainly due to the companies stabilizing their production after meeting the demand which increased exponentially during the COVID -19 pandemic in 2020. The anti-infective drugs market share is expected to reach $614.29 billion in 2026 with a CAGR of 25.6%.According to the anti-infective drug industry analysis, the market is expected to benefit from the latest drug developments. discovery procedures such as stem cells and organ-on-a-chip (OOC) technologies.

Request a sample now to better understand the anti-infective drugs market:

Key Anti-Infective Drugs Market Trends
Manufacturers of anti-infective drugs invest in drug development programs to treat drug-resistant infections. Antimicrobial resistance is a serious concern for global public health because it leads to a long duration of illness, the need for additional testing and the use of more expensive drugs. Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, parasites, and fungi change and adapt to drugs when exposed to antimicrobial drugs such as antibiotics, antivirals, antifungals , anthelmintics and others. According to the World Health Organization (WHO), 4,80,000 people worldwide are affected each year by multidrug-resistant tuberculosis, and drug resistance is also beginning to complicate the treatment of malaria and HIV. Companies are investing in the development of new drug candidates to treat drug-resistant infections. For example, in 2019, the combination of antibacterial agents imipenem, cilastatin and relebactam, pretomanid, lefamulin and cefiderocol was approved by the US FDA for the treatment of resistant bacteria for specific indications.

Anti-Infective Drugs Market Overview
The anti-infective drugs market includes sales of branded and generic anti-infective drugs and related services by entities (organizations, individual traders and partnerships) that manufacture branded or generic anti-infective drugs to treat microbial infections . The anti-infective drugs industry includes establishments that manufacture antibiotics to treat bacterial infections, antiviral drugs to treat viral infections, antifungal drugs to treat fungal infections, antihelminthic drugs to kill internal parasites, and antiprotozoal drugs to treat protozoal infections. .

To learn more about the Global Anti-Infective Drugs Market report, visit:

TBRC Global Anti-Infective Drugs Market Report 2022 covers the following insights:
Market Size Data
• Forecast period: historical and future
• By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, United States, South America, Middle East and Africa.
• By country: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom, USA.
Market segmentation
• By type: antibiotics, antivirals, antifungals, others (anthelmintics, antiprotozoals)
• By distribution channel: hospital pharmacies, retail pharmacies/pharmacies, other
• By route of administration: oral, parenteral, other
• By drug classification: brand name drugs, generic drugs
• By mode of purchase: prescription drugs, over-the-counter drugs
• By Geography: Global Anti-Infective Drugs market report is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East & Africa. Among these regions, North America holds the largest market share.

Major market players such as Gilead Sciences, GlaxosmithKline, Merck & Co, Johnson & Johnson, Pfizer Inc., AbbVie, Bayer AG, Mylan NV, Shionogi, and F. Hoffmann-La Roche Ltd.
Trends, opportunities, strategies and much more.

The Global Anti-Infective Drugs Market Report 2022 is one of the comprehensive reports by The Business Research Company that provides an overview of the Anti-Infective Drugs Market. The market report analyzes the global anti-infective drugs market size, global anti-infective drugs market growth drivers, global anti-infective drugs market segments, global anti-infective drugs market major players, anti-infectives, the growth of the anti-infective drugs market in all geographies and anti-infectives. the income of competitors in the infectious drugs market and their positioning in the market. The Anti-Infective Drugs market report allows you to gain insight into opportunities and strategies, as well as identify countries and segments with the highest growth potential.

Not what you were looking for? Browse similar reports from The Business Research Company:

Global Vaccines Market Report 2022

Global Antivirals Market Report 2022

Global Monoclonal Antibody (MAb) Market Report 2022

About the business research company?
The Business Research Company has published over 3,000 industry reports covering over 3,000 market segments and 60 geographies. The reports are based on 150,000 datasets, extensive secondary research and proprietary insights from interviews with industry leaders. Reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Contact information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Discover our:
TBRC Blog:

Olivier Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:

Market Research Products, Services and Solutions for Your Business – TBRC

Comments are closed.